Strategic Transformation | 19 Patents | PSPO™ | PSM™ | LSSWB | LSSYB | LPLG | Microsoft Power BI Certified | Program And Project Management | Vendor Management | Operational Excellence| Data Analytics
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/dZ2bjF3P
Passionate Life Sciences Leader | Fast-Tracking Treatments for Patients | Making a Positive Difference ❤️ | HBA Ambassador Champion | WEN (Women Empowerment Network) India Co-Lead
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/g6eWJThN
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/eMR3P57E
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/e_GS-9B7
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/dzgY8QyG
Inside Sales Manager-CRO-Changing the present;"Every great advance in science has issued from a new audacity of the imagination." John Dewey #fortreaforward #experiencematters
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/gJx8BXrV
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. #FortreaAlwaysOn https://lnkd.in/ditmnABJ
How can complex innovative designs, meta-analytic predictive models and new statistical approaches help overcome the unique challenges of rare disease clinical trials? Download our white paper to explore groundbreaking strategies to accelerate the path to effective rare disease treatments: https://ow.ly/ijvX30sCYYo #SyneosHealth
From cell type-specific studies to inflammatory bowel disease research, discover how we are making groundbreaking studies possible. Hear from some of our research partners on how we are supporting them deliver their research. https://lnkd.in/eAjKEijD #MedicalResearch #BioResource
📣 A new publication from Team Schlossmacher focuses on understanding the correlation between loss of smell in COVID-19 and #ParkinsonsDisease patients. The report shows that post-mortem olfactory tissue of COVID-19 patients resembles #neurodegenerative disease processes. Learn more about Team Schlossmacher's findings: https://lnkd.in/ehtUPydM
Don't miss out on our FREE meeting! Tuesday 12 November 18:30-20:30 TED series *National meeting series on thyroid eye disease*. Join Jimmy Uddin senior oculoplastic consultant Moorfields Eye Hospital, London, for TED assessment. Discussion will be around the following topics: ➡️ The value of phenotypes for outcome and therapeutic options ➡️ CAS score What is its value today? ➡️ What is disease severity? Pitfalls and learning ➡️ Motility- Have we lost how to assess it? ➡️ Imaging - When is it useful? Book your space https://lnkd.in/eZBkCp3i
